Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The data from the SURPASS trials was used to secure the May 2022 approval for diabetes
Research has demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles
Even a single month of GobyMeds compounded tirzepatide at $299 represents a fraction of those prices
Offered since May 2023, Wahood said 50 patients have started taking the weekly injections
US$ 22.98
US$ 21.86
US$ 22.89
US$ 24.76
US$ 22.79
US$ 20.94
US$ 28.64
US$ 20.46
US$ 20.05
US$ 29.21
